Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1125258

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the incidence of ovarian cancer; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	251890
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>Prevention is a key focus of the NHS Long Term Plan, which sets out plans to tackle risk factors for cancer such as obesity, alcohol consumption and smoking. This will have a significant impact on improving health, including for those who are at risk of developing ovarian cancer. Over the next 10 years the National Health Service will extend the use of molecular diagnostic testing and routine offering genomic testing to all patients with cancer for whom it would be of clinical benefit.</p><p>From 2019 we will start the roll-out of new Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise, building on 10 models piloted with Cancer Research UK, which have focused on diagnosing cancers where patients often present with non-specific symptoms, often the case with ovarian cancer, and may go to their general practitioner many times before being sent for tests, such as blood and stomach cancers.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:44:05 answering member 4455 label Biography information for Seema Kennedy
tabling member	253 label Biography information for Mr Laurence Robertson

1125259

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the treatment of ovarian cancer; and if he will make a statement.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	251891
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The NHS Cancer Programme is committed through the NHS Long Term Plan to improve access to treatments for all cancer patients and reduce health inequalities. Cancer Alliances are working with local sustainability and transformation partnerships and integrated care systems to reduce variation on patient outcomes and experience.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:43:12 answering member 4455 label Biography information for Seema Kennedy
tabling member	253 label Biography information for Mr Laurence Robertson

1125271

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many deaths were caused by Chronic obstructive pulmonary disease in affected areas in England during the air pollution episode in April 2019; and what comparative assessment he has made of the figures for that period with (a) expected average and (b) average over the last five years.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	251937
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>According to the Daily Air Quality Index (DAQI) there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for deaths caused by chronic obstructive pulmonary disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019 the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:46:29 answering member 4455 label Biography information for Seema Kennedy
tabling member	1516 label Biography information for Andy Slaughter

1125324

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department is making on introducing comprehensive calorie labelling for food and drink served out of the home; and when his Department plans to publish the results of the consultation on that matter, which closed on 25 October 2018.
tabling member constituency	Dewsbury
tabling member printed	Paula Sherriff
uin	252038
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The consultation on calorie labelling for food and drink served outside of the home took place between 14 September and 7 December 2018. We will publish the results and set out the timetable for further action later this year.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:45:07 answering member 4455 label Biography information for Seema Kennedy
tabling member	4426 label Biography information for Paula Sherriff

1125378

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 May 2019 to Question 249880, which local authorities have received funding to deliver the trailblazer programme.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	251921
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The local authorities that have gone through to the discovery phase of the Trailblazer Programme and received funding are:</p><p> </p><p>- Bath and North East Somerset Council;</p><p>- Birmingham City Council;</p><p>- Blackburn with Darwen Council;</p><p>- City of Bradford Metropolitan District Council;</p><p>- London Borough of Havering;</p><p>- London Borough of Lewisham;</p><p>- Middlesbrough Council;</p><p>- North Tyneside Council;</p><p>- North Yorkshire County Council;</p><p>- Nottinghamshire County Council;</p><p>- Peterborough City Council;</p><p>- Rochdale Borough Council; and</p><p>- Walsall Council.</p><p> </p><p>The next phase of the Trailblazer Programme begins early this summer when five authorities will be selected from this list to take forward their plans to address childhood obesity at local level over the next three years.</p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 16:03:00 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1125380

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, how many times his Department has sought information relating to bespoke medicines from small producers with an annual NHS turnover of less than £5 million; and whether he plans to make an assessment on the potential merits of requiring all small producers to automatically supply quarterly information on those medicines.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	252063
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) prescribe when manufacturers, importers and wholesalers of special medicinal products are required to provide information. Since the Regulations entered into force, quarterly information has been received in November 2018 and February 2019 and information is again due at the end of May 2019. The requirement to provide quarterly sales, purchase and volume information about special medicinal products already applies to all manufacturers, importers and wholesalers regardless of their size. Therefore, there is no need for an assessment on the potential merits of requiring all small producers to automatically supply quarterly information.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 252064 question first answered 13/05/2019 15:40:15 answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1125381

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, what criteria his Department uses to decide on which small producers to seek information from.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	252064
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) prescribe when manufacturers, importers and wholesalers of special medicinal products are required to provide information. Since the Regulations entered into force, quarterly information has been received in November 2018 and February 2019 and information is again due at the end of May 2019. The requirement to provide quarterly sales, purchase and volume information about special medicinal products already applies to all manufacturers, importers and wholesalers regardless of their size. Therefore, there is no need for an assessment on the potential merits of requiring all small producers to automatically supply quarterly information.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 252063 question first answered 13/05/2019 15:40:15 answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1125382

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, what steps he is taking to ensure that (a) wholesalers and (b) importers are providing his Department with information on medicines.
tabling member constituency	Newton Abbot
tabling member printed	Anne Marie Morris
uin	252065
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The Department is undertaking an exercise to ensure that all companies that are required to provide quarterly information under the Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) are doing so. Where they are not, the Department will consider taking the appropriate action provided for in the Regulations.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:39:14 answering member 4455 label Biography information for Seema Kennedy
tabling member	4249 label Biography information for Anne Marie Morris

1124982

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 April 2019 to Question 244142 on Cannabis: Medical Treatments, whether his Department defines Naboline as a cannabis imitating rather than cannabis derived product.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	251364
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The Department recognises both Nabilone and Sativex as licensed cannabis-based medicines. Neither, however, falls within the scope of the definition of a ‘cannabis-based product for medicinal use’ under the recent change to the law.</p><p>Nabilone is a synthetic non-natural cannabinoid that mimics delta-9-tetrahydrocannabinol (THC). It was issued a marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA), for nausea and vomiting caused by chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments, on 14 February 1995. There are no restrictions on its prescribing in the National Health Service.</p><p>Sativex (nabiximols) is an oromucosal spray that contains THC and cannabidiol (CBD). It was issued a marketing authorisation by the MHRA, for treatment of spasticity in people with multiple sclerosis who have failed to respond adequately to other anti-spasticity medications, on 16 June 2010. In October 2014, the National Institute for Health and Care Excellence recommended that Sativex is not offered for use on the NHS because it is not a cost-effective treatment. Sativex therefore is not routinely prescribed on the NHS, and can only be prescribed for an individual patient, where local governance and funding arrangements allow for this.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 251366 question first answered 13/05/2019 15:38:24 answering member 4455 label Biography information for Seema Kennedy
tabling member	4425 label Biography information for Jo Stevens

1124983

registered interest
date	07/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 April 2019 to Question 244142 on Cannabis: Medical Treatments, whether his Department is aware of any instances of (a) CBD and (b) THC being prescribed by the NHS since 1 January 2019.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	251365
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>The published data shows that the following number of items of Nabilone (a synthetic product which mimics tetrahydrocannabinol (THC)) and Sativex (a product containing natural THC and cannabidiol (CBD)) were dispensed in January and February 2019.</p><p> </p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>Number of prescription items</p></td></tr><tr><td><p> </p></td><td><p>January 2019</p></td><td><p>February 2019</p></td></tr><tr><td><p>Nabilone</p></td><td><p>44</p></td><td><p>36</p></td></tr><tr><td><p>Sativex</p></td><td><p>167</p></td><td><p>159</p></td></tr></tbody></table><p> </p><p>Data, from the NHS Business Services Authority for January and February 2019, suggest that three National Health Service prescriptions were dispensed for unlicensed cannabis-based products for medicinal use in primary care in England during this time. Additionally, the NHS Business Services Authority data report that 10 private prescriptions were dispensed for unlicensed cannabis-based products for medicinal use in January and February 2019.</p><p> </p><p>Unlike NHS primary care where all dispensed prescriptions are processed centrally, this is not the case for secondary care. This information is collected by a third party and not routinely published.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 16:07:00 answering member 4455 label Biography information for Seema Kennedy
tabling member	4425 label Biography information for Jo Stevens